Chronosome

Chronosome Inc

0 Investors
Biotechnology
Los Angeles, CA

Chromos Molecular Systems Inc. is a biotechnology company focused on enhancing the development and manufacturing processes of complex biological therapies through proprietary chromosome-based engineering technologies. The company aims to meet the growing demands of biopharmaceutical firms for advanced solutions in therapeutic design and production.

Products & Team

ACE System (Artificial Chromosome Expression System)

Cell line engineeringSeed

The ACE System is designed for engineering stable cell lines that express therapeutic proteins. This technology simplifies the cell line development process while ensuring high yield and quality of the product.

Value Proposition

The ACE System addresses the challenges faced in developing and manufacturing complex biological therapies, ultimately enhancing the productivity of biopharmaceutical companies.

Pain Points

The need for efficient and scalable production methods for complex biological therapeutics, as well as the challenge of designing stable and effective cell lines.

Proprietary chromosome-based engineeringStreamlined cell line developmentHigh scalability for production
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
Los Angeles, CA
Primary headquarters

Funding History

0
E

Other Offering

May 2025
$550.0K
Target
Progress
0%
Raised
$0
Target
$550.0K
#000196496525000006